| Tap a line for its trend | Last 12Mto Sep 2026 | FY26Mar 2026 | FY25Mar 2025 | FY24Mar 2024 | FY23Mar 2023 | FY22 and earlierAlpha Plus |
|---|
| 60.17× | 60.17× | 61.32× | 56.51× | 54.40× | FY22 and earlierEvery year the company has filed comes with Alpha Plus. | |
| −3.82× | −3.46× | −4.35× | −2.69× | −4.22× | ||
| 0.90× | 0.90× | 0.90× | 0.93× | 0.89× | ||
| 4.49× | 4.49× | 1.58× | 3.28× | 2.43× | ||
| 0.93× | 0.93× | 0.64× | 0.75× | 1.02× |
From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.
Ratios — % unless marked × 12 Months Ending | FY23 31/03/2023 | FY24 31/03/2024 | FY25 31/03/2025 | FY26 31/03/2026 | Last 12M 30/09/2026 | |
|---|---|---|---|---|---|---|
| Receivable Days (DSO) | 54.40 | 56.51 | 61.32 | 60.17 | 60.17 | |
| Working Capital Turnover | -4.22 | -2.69 | -4.35 | -3.46 | -3.82 | |
| Asset Turnover | 0.89 | 0.93 | 0.90 | 0.90 | 0.90 | |
| Cash Conversion (CFO/Net Income) | 2.43 | 3.28 | 1.58 | 4.49 | 4.49 | |
| CFO/EBITDA | 1.02 | 0.75 | 0.64 | 0.93 | 0.93 |